Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to -$0.61.

  • Coeptis Therapeutics Holdings' EPS (Basic) fell 122962.48% to -$0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.61, marking a year-over-year decrease of 10925.22%. This contributed to the annual value of -$5.65 for FY2024, which is 6586.39% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported EPS (Basic) of -$0.61 as of Q3 2025, which was down 122962.48% from -$1.17 recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' EPS (Basic) registered a high of -$0.03 during Q1 2021, and its lowest value of -$2.92 during Q4 2023.
  • For the 5-year period, Coeptis Therapeutics Holdings' EPS (Basic) averaged around -$0.71, with its median value being -$0.41 (2022).
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 485477.71% in 2022, then soared by 8085.62% in 2024.
  • Over the past 5 years, Coeptis Therapeutics Holdings' EPS (Basic) (Quarter) stood at -$0.03 in 2021, then crashed by 570.42% to -$0.21 in 2022, then crashed by 1320.24% to -$2.92 in 2023, then soared by 46.48% to -$1.56 in 2024, then skyrocketed by 60.96% to -$0.61 in 2025.
  • Its EPS (Basic) was -$0.61 in Q3 2025, compared to -$1.17 in Q2 2025 and -$1.11 in Q1 2025.